参考文献/References:
［1］WHO Guidelines Approved by the Guidelines Review Committee WHO recommendations on interventions to improve preterm birth outcomes ［Z］, 2015，19 (1):234-243.
［2］Di Renzo GC,Cabero Roura L,Facchinetti F.Preterm labor and birth management:Recommendations from the European Association of Perinatal Medicine ［J］. The Journal of Maternal-Fetal & Neonatal Medicine，2017，30 （17）：2011-2030．
［3］FLENADY V, WOJCIESZEK A M, PAPATSONIS D N, et al. Calcium channel blockers for inhibiting preterm labour and birth ［J］. The Cochrane Database of Systematic Reviews, 2015，43 (3):192-198.
［4］KOMATSU Y, MCKAIN L, POWELL M. Prevention of spontaneous preterm birth:Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians(CNGOF).Eur J Obstet Gynecol Reprod Biol ［Z］, 2017: 130.
［5］ANOTAYANONTH S, SUBHEDAR N V, GARNER P, et al. Betamimetics for inhibiting preterm labour ［J］. The Cochrane Database of Systematic Reviews, 2014，2 (2):CD004352.
［6］SMITH V, DEVANE D, BEGLEY C M, et al. A systematic review and quality assessment of systematic reviews of randomised trials of interventions for preventing and treating preterm birth ［J］. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2009, 142 (1): 3-11.
［7］OGOYAMA M, TAKAHASHI H, KOBAYASHI Y, et al. Ritodrine-induced rhabdomyolysis,infantile myotonic dystrophy ［J］. The Journal of Obstetrics and Gynaecology Research, 2017, 43 (2): 403-407.
［8］DORET M, KAYEM G. Tocolysis for preterm labor without premature preterm rupture of membranes ［J］. Journal de Gynecologie, Obstetrique et Biologie de La Reproduction, 2016, 45(10): 1374-1398.
［9］FDA. FDA Drug Safety Communication: New warnings against use of terbutaline to treat preterm labor. 2011［EB/OL］.https://www.fda.gov/Drugs/DrugSafety/ucm243539.htm.
［10］PAPATSONIS D, FLENADY V, COLE S, et al. Oxytocin receptor antagonists for inhibiting preterm Labour ［J］. The Cochrane Database of Systematic Reviews, 2005，110(1):180-181:
［11］JRGENSEN J S, WEILE L K, LAMONT R F. Preterm labor: current tocolytic options for the treatment of preterm labor ［J］. Expert Opinion on Pharmacotherapy, 2014, 15 (5): 585-588.
［12］REINEBRANT H E, PILEGGI-CASTRO C, ROMERO C L, et al. Cyclo-oxygenase (COX) inhibitors for treating preterm Labour ［J］. The Cochrane Database of Systematic Reviews, 2015 (6): CD001992.
［13］SOOD B G, LULIC-BOTICA M, HOLZHAUSEN K A, et al. The risk of necrotizing enterocolitis after indomethacin tocolysis ［J］. Pediatrics, 2011, 128 (1): e54-e62.
［14］CROWTHER C A, MIDDLETON P F, VOYSEY M, et al. Assessing the neuroprotective benefits for babies of antenatal Magnesium sulphate: An individual participant data meta-analysis ［J］. PLOS Medicine, 2017, 14 (10): e1002398.
［15］KIM M K, LEE S M, OH J W, et al. Efficacy and side effect of ritodrine and Magnesium sulfate in threatened preterm labor ［J］. Obstetrics & Gynecology Science, 2018, 61 (1): 63-70.
［16］HAGHIGHI L, RASHIDI M, NAJMI Z, et al. Comparison of intramuscular progesterone with oral nifedipine for treating threatened preterm labor:A randomized controlled trial ［Z］, 2017: 56.
［17］刘洋铭，王寒冰，漆洪波．美国妇产科医师学会早产管理指南2016年补充公告解读 ［J］．中国实用妇科与产科杂志，2016，32 （12）：1189-1192．
［18］ROMERO R, DEY S K, FISHER S J. Preterm labor: one syndrome, many causes ［J］. Science (New York, N.Y.), 2014, 345 (6198): 760-765.
［19］中华医学会妇产科分会产科学组．前置胎盘的诊断与处理指南 ［J］．中华妇产科杂志，2013，48 （2）：148-150．
［20］YINKA O, ANTHONY M V. Placental abruption ［J］. 中国妇产科临床杂志, 2006，7 (5): 398-399.
相似文献/References:
[1]张泽华,陈晓勤,赵小玉,等.早产与社会环境因素[J].中国计划生育和妇产科,2010,(04):0.
ZHANG Ze-hua,CHEN Xiao-qin,ZHAO Xiao-yu,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(11):0.
[2]严琴,祝茹.57例早产胎膜早破孕妇的支原体检测分析[J].中国计划生育和妇产科,2011,(02):0.
[3]顾敏贞,朱梅英,杨祖铭,等.区域内胎龄≤33周早产儿不同转运模式与预后关系的研究[J].中国计划生育和妇产科,2013,(06):0.
Gu Min-zhen,ZHU Mei-ying,Yang Zu-ming,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(11):0.
[4]邹丽颖,张为远.早产诊断的变迁[J].中国计划生育和妇产科,2015,(04):0.
[5]马玉燕,朱晓丹.早产的妊娠结局[J].中国计划生育和妇产科,2015,(04):0.
[6]付晶,苟文丽.早产相关因素研究进展[J].中国计划生育和妇产科,2015,(04):0.
[7]刘小华,程蔚蔚.早产的药物治疗[J].中国计划生育和妇产科,2015,(05):0.
[8]何书励,马良坤,刘俊涛,等.早产和营养[J].中国计划生育和妇产科,2015,(05):0.
[9]虞娇,周琼洁,李笑天,等.早产预测的临床应用价值评价[J].中国计划生育和妇产科,2015,(05):0.
[10]杜楚颖,张建平.早产的预防[J].中国计划生育和妇产科,2015,(05):0.